"while Achillion's submission addressed all issues noted in the FDA's June 29, 2013 letter, the FDA concluded that the removal of the clinical hold is not warranted."
http://eon.businesswire.com/news/eon/20130930006621/en/Wolf-Haldenstein-Announces-Investigation-Achillion-Pharmaceuticals
http://eon.businesswire.com/news/eon/20130930006621/en/Wolf-Haldenstein-Announces-Investigation-Achillion-Pharmaceuticals
No comments:
Post a Comment